Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme

Raynor Lewis; Batista Julie; Carloni Laura; Gudivada Badari; Lewis Grace; Sekulic Davorka; Tsang So-Fai

首页> 外文期刊>Molecular genetics and metabolism >Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme

【24h】

Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme

机译：妊娠石竹酶治疗患者的现实世界成果：来自全球安全数据库和国际协同Gaucher集团的数据（ICGG）Gaucher注册表怀孕子注册表由Sanofi Genzyme维护

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Molecular genetics and metabolism》 |2019年第2期|共1页
作者
Raynor Lewis; Batista Julie; Carloni Laura; Gudivada Badari; Lewis Grace; Sekulic Davorka; Tsang So-Fai;
展开▼
作者单位

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

Sanofi Genzyme Cambridge MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献

1. Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme [J] . Raynor Lewis, Batista Julie, Carloni Laura, Molecular genetics and metabolism . 2019,第2期

机译：妊娠石竹酶治疗患者的现实世界成果：来自全球安全数据库和国际协同Gaucher集团的数据（ICGG）Gaucher注册表怀孕子注册表由Sanofi Genzyme维护
2. Clinical response to eliglustat in treatment-na?ve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry [J] . Jennifer Ibrahim, Lisa H. Underhill, John S. Taylor, Molecular Genetics and Metabolism Reports . 2016,第1期

机译：国际合作Gaucher Group Gaucher Registry登记的初治Gaucher疾病类型1的初治患者对eliglustat的临床反应：事后比较与伊米苷酶治疗的患者
3. Risk factors for fracture in imiglucerase-treated Gaucher disease type 1 patients in the ICGG Gaucher Registry [J] . Deegan Patrick B., Batista Julie Molecular genetics and metabolism . 2016,第2期

机译：ICGG Gaucher Registry中经伊米苷酶治疗的1型Gaucher病患者骨折的危险因素
4. Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry [O] . Jennifer Ibrahim, Lisa H. Underhill, John S. Taylor, 2016

机译：国际合作Gaucher集团Gaucher注册中心的未接受过Gaucher疾病类型1的初治患者对依格鲁司特的临床反应：事后比较与伊米苷酶治疗的患者
5. Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry [O] . Jennifer Ibrahim, Lisa H. Underhill, John S. Taylor, 2016

机译：高血压患者接受eliglustat对戈谢病1型患者的临床反应：对伊米格拉酶治疗患者进行事后比较，参加国际协作高斯组高斯登记处

Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme

著录项

相似文献

相关主题

期刊订阅